Identification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections

Vista sencilla de ítem
dc.contributor.authorBertrand, Pablo J.
dc.contributor.authorVázquez, Yaneisi
dc.contributor.authorBeckhaus, Andrea A.
dc.contributor.authorGonzález, Liliana A.
dc.contributor.authorContreras, Ana María
dc.contributor.authorFerres, Marcela
dc.contributor.authorPadilla, Oslando
dc.contributor.authorRiedel, Claudia A.
dc.contributor.authorKalergis, Alexis M.
dc.contributor.authorBueno, Susan M.
dc.date.accessioned2024-04-11T23:51:54Z
dc.date.available2024-04-11T23:51:54Z
dc.date.issued2022-10
dc.descriptionIndexación: Scopus.
dc.description.abstractLower respiratory tract infections (LRTIs) produced by viruses are the most frequent cause of morbidity and mortality in children younger than 5 years of age. The immune response triggered by viral infection can induce a strong inflammation in the airways and cytokines could be considered as biomarkers for disease severity as these molecules modulate the inflammatory response that defines the outcome of patients. Aiming to predict the severity of disease during respiratory tract infections, we conducted a 1-year follow-up observational study in infants who presented upper or lower respiratory tract infections caused by seasonal respiratory viruses. At the time of enrollment, nasopharyngeal swabs (NPS) were obtained from infants to measure mRNA expression and protein levels of IL-3, IL-8, IL-33, and thymic stromal lymphopoietin. While all cytokines significantly increased their protein levels in infants with upper and lower respiratory tract infections as compared to control infants, IL-33 and IL-8 showed a significant increase in respiratory syncytial virus (RSV)-infected patients with LRTI as compared to patients with upper respiratory tract infection. We also found higher viral loads of RSV-positive samples with a greater IL-8 response at the beginning of the symptoms. Data obtained in this study suggest that both IL-8 and IL-33 could be used as biomarkers for clinical severity for infants suffering from LRTIs caused by the RSV. © 2022 The Author(s). Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved.
dc.description.urihttps://watermark.silverchair.com/uxac083.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA0swggNHBgkqhkiG9w0BBwagggM4MIIDNAIBADCCAy0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMwnJgrZRyWxkcQcd1AgEQgIIC_jOwqN4vqBYeI0h308jErE_yopcfnucx2P_sfI0RocOxJCzDoc8Y9VK_2H1hZuSfk3NxHgsnPZomEXjeTroymMVCJv-noBx813oSeTJaII-7HSMdNZo0Q0GjsH71_HiuiqyI-RMs5ED91mLMoGQn7romhQvIb4MbFUO_LQ03fhUrfYB1K7UbMCeWsQoSSpqGMWkYfQygPX8S2NF8fNigXuklf5XRAkg1lfRMR-Mjm3QpnXQKv-aB8B1zsxZsu-TfY9w1pnrtj4DoK4jIIY4WfvXkKQ0VrqIkpQDITvusjHT2DjnM9tUwGKcYBtr0shiGxd0UE3TMOL8LQFYyTjEMPJiUousGh32xnOQcYCttSif7uViuwaUUImtBKJYvORet8bQSPnfaBsF-BeRrRM6BjgFoYlIfXDF5jgSi1rOulYUgY6Qc37T4siSLUWVFy_QjG08NwkqDW-8C2m4IUKjyd-Zo-z-zhesvBvujSPs0lxM9pJoITgrbVgvhEMHuOJspo_EVrlWKRHXV8bfd2CiJR-jRf8_lk9uhPHG1IxjlzW7cSQJe-3gcjlHPcyDFDOlxtMxWCiuSq-Yn-92us89jHhCJAIizq1gwc6f7kCshM2dTAxDdpPmsPcqrU4AZDcXr8AUNRICAXRgef6OqJytsmZxcUpvSBjqWmwhtXslP0Pr19SPg15xsOKzeClmT31zqTi0rqubRMZAwBUp58D-zjtsZWyqhDwztIqyt-fUVzXQU8WOHO6SB2XD0a4eUXG13BEPi0KcYQfLjFl9nE4sGF3hMnWUi9m6mbiW_ZVGQryNLK6PUJ7l0arjVdpp8UW1yeLYuDQBtsiaJEWN4-qw35kw6mQf1KyYsse6YjTTcVtSK94Hz6haDRZlMsdCOPtGG5LM6q3iA_k0RDhIP-0QZJjwNDbbY4hzx4sCmBY36w0avdflIDulsYNdblg3BPsRn_JLqPjt9Rbx4q6UZvtV9FBvLCUUWj6X56yZYLxmZcS6GEDa4J210ODGlNyYERrM
dc.identifier.citationClinical and Experimental Immunology, Volume 210, Issue 1, Pages 68 - 78, October 2022
dc.identifier.doi10.1093/cei/uxac083
dc.identifier.issn0009-9104
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/55885
dc.language.isoen
dc.publisherOxford University Press
dc.rights.licenseCC BY-NC 4.0 DEED Atribución-NoComercial 4.0 Internacional
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/deed.es
dc.subjectCytokines
dc.subjectRespiratory tract infection
dc.subjectRSV
dc.subjectBiomarkers
dc.subjectChild
dc.subjectHumans
dc.subjectInfant
dc.subjectInterleukin-3
dc.subjectInterleukin-33
dc.subjectInterleukin-8
dc.subjectRespiratory Syncytial Virus Infections
dc.subjectRespiratory Syncytial Viruses
dc.subjectRNA, Messenger
dc.subjectSeverity of Illness Index
dc.subjectViruses
dc.titleIdentification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections
dc.typeArtículo
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Bertrand_Identification_of_biomarkers_for_disease.pdf
Tamaño:
859.78 KB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista